{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:41:54Z","timestamp":1790746914165,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1684\/bdc.2014.2013","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:43Z","timestamp":1565726323000},"page":"657-662","source":"Crossref","is-referenced-by-count":6,"title":["Papillomavirus et cancers : plaidoyer pour un \u00e9largissement de la vaccination aux gar\u00e7ons"],"prefix":"10.1016","volume":"101","author":[{"given":"Laurent","family":"Abramowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Aliette","family":"Dommergues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lacau St Guily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerric","family":"Masse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Judlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2014.2013_bib0005","first-page":"11","article-title":"Monograph comprehensive control of HPV infections and related diseases. Comprehensive control of Human Papillomavirus infections and related diseases","volume":"31S","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1684\/bdc.2014.2013_bib0010","unstructured":"Comit\u00e9 technique des vaccinations et Conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France : \u00ab Avis du CTV et du CSHPF relatif \u00e0 la vaccination contre les Papillomavirus humains 6, 11, 16 et 18. S\u00e9ance du 9 mars 2007 \u00bb : http:\/\/www.hcsp.fr\/docspdf\/cshpf\/a_mt_090307_papillomavirus.pdf."},{"key":"10.1684\/bdc.2014.2013_bib0015","unstructured":"Le calendrier des Vaccinations et les recommandations vaccinales 2013 selon l\u2019Avis du Haut Conseil de la sant\u00e9 publique. Bull Epidemiol Hebd 2013 ; 14-15. www.invs.sante.fr\/beh\/."},{"key":"10.1684\/bdc.2014.2013_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.medmal.2013.03.006","article-title":"Vaccination des ados : mission impossible ?","volume":"43","author":"Gaudelus","year":"2013","journal-title":"Med Mal Infect"},{"key":"10.1684\/bdc.2014.2013_bib0025","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit (RCP) Gardasil\u00ae. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d124."},{"key":"10.1684\/bdc.2014.2013_bib0030","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit (RCP) Cervarix\u00ae, 2013. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/evamed\/CT-12715_CERVARIX_RI_Avis2_CT%2012715.pdf."},{"key":"10.1684\/bdc.2014.2013_bib0035","series-title":"Gardasil \u00ae: troisi\u00e8me bilan du plan de gestion des risques europ\u00e9en et national","year":"2011"},{"key":"10.1684\/bdc.2014.2013_bib0040","unstructured":"Le 1er bilan du PGR de Cervarix\u00ae : http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/4996b1fadf2eabc77cb08d048f340aa8.pdf."},{"key":"10.1684\/bdc.2014.2013_bib0045","unstructured":"Avis du Haut Conseil de la sant\u00e9 publique relatif au vaccin Gardasil\u00ae et \u00e0 la strat\u00e9gie de pr\u00e9vention globale des cancers du col de l\u2019ut\u00e9rus du 21 octobre 2011 : http:\/\/www.hcsp.fr\/docspdf\/avisrapports\/hcspa20111021_gardasil.pdf."},{"key":"10.1684\/bdc.2014.2013_bib0050","unstructured":"ANSM. Gardasil : vaccination contre les papillomavirus humains (HPV) - Point d\u2019information (26\/11\/2013). http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Gardasil-vaccination-contre-les-papillomavirus-humains-HPV-Point-d-information."},{"key":"10.1684\/bdc.2014.2013_bib0055","unstructured":"Rappel d\u2019information sur Gardasil, information du minist\u00e8re des Affaires sociales et de la Sant\u00e9 (06\/12\/2013). http:\/\/ansm.sante.fr\/content\/download\/56543\/727079\/version\/1\/file\/Gardasil_Point_d_information_061213-ministere-+sante.pdf."},{"key":"10.1684\/bdc.2014.2013_bib0060","unstructured":"HCSP, Haut Conseil de la sant\u00e9 publique, Rapport du groupe de travail 21 octobre 2011. Le vaccin Gardasil\u00ae et la strat\u00e9gie de pr\u00e9vention globale des cancers du col de l\u2019ut\u00e9rus. Collection Avis et Rapports. (Chapitre 4.2.1 - \u00c9tude de cohorte sur les donn\u00e9es du SNIIRAM). http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=231."},{"key":"10.1684\/bdc.2014.2013_bib0065","series-title":"J Intern Med","article-title":"Autoimmune disorders and quadrivalent Human Papillomavirus vaccination of young female subjects","author":"Grimaldi-Bensouda","year":"2013"},{"key":"10.1684\/bdc.2014.2013_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent Human Papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"key":"10.1684\/bdc.2014.2013_bib0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/INF.0b013e318149dfea","article-title":"Human Papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions","volume":"26","author":"Siegrist","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1684\/bdc.2014.2013_bib0080","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/ijc.24476","article-title":"Impact of human papillomavirus vaccination depends on effective vaccination strategy","volume":"125","author":"Lehtinen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2014.2013_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1684\/bdc.2014.2013_bib0090","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"key":"10.1684\/bdc.2014.2013_bib0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/jir285","article-title":"Incremental impact of adding boys to current Human Papillomavirus vaccination programs: role of herd immunity","volume":"204","author":"Brisson","year":"2011","journal-title":"J Infect D"},{"key":"10.1684\/bdc.2014.2013_bib0100","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/488S10a","article-title":"Vaccinate boys too","volume":"488","author":"Stanley","year":"2012","journal-title":"Nature"},{"key":"10.1684\/bdc.2014.2013_bib0105","unstructured":"Institut national de lutte contre le cancer. Donn\u00e9es de l\u2019agence nationale sanitaire et scientifique en canc\u00e9rologie disponible en ligne sur le site de l\u2019INCA, 2014. https:\/\/lesdonnees.e-cancer.fr\/les-fiches-de-synthese\/29-incidence-mortalite\/86-cancers-voies-aerodigestives-superieures-vads\/167-epidemiologie-cancers-levre-bouche-pharynx-france-incidence-mortalite.html."},{"key":"10.1684\/bdc.2014.2013_bib0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.oraloncology.2012.12.005","article-title":"Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care","volume":"49","author":"Oskam","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1684\/bdc.2014.2013_bib0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human Papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2014.2013_bib0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with Human Papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2014.2013_bib0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of Human Papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"Nasman","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2014.2013_bib0130","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human Papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2013_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcv.2011.03.003","article-title":"Human Papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study","volume":"51","author":"Lacau St Guily","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1684\/bdc.2014.2013_bib0140","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","article-title":"Evaluation of Human Papillomavirus antibodies and risk of subsequent head and neck cancer","volume":"31","author":"Kreimer","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2013_bib0145","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"key":"10.1684\/bdc.2014.2013_bib0150","series-title":"Cancer incidence in five continents Vol. IX IARC Scientific Publication No 160","author":"Curado","year":"2007"},{"key":"10.1684\/bdc.2014.2013_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.respe.2010.06.165","article-title":"Economic burden of anal cancer management in France","volume":"58","author":"Abramowitz","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1684\/bdc.2014.2013_bib0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ogc.2009.02.003","article-title":"The epidemiology of anal Human Papillomavirus and related neoplasia","volume":"36","author":"Palefsky","year":"2009","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1684\/bdc.2014.2013_bib0165","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1200\/JCO.2012.44.5486","article-title":"Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV","volume":"30","author":"Piketty","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2013_bib0170","unstructured":"Prise en charge m\u00e9dicale des personnes vivant avec le VIH. Recommandations du groupe d\u2019experts RAPPORT 2013. http:\/\/www.sante.gouv.fr\/rapport-2013-sur-la-prise-en-charge-medicale-des-personnes-vivant-avec-le-vih.html."},{"key":"10.1684\/bdc.2014.2013_bib0175","series-title":"16th International Meeting of the European Society of Gynaecological Oncology (ESGO)","article-title":"Human papillomavirus genotype distribution in anal cancer in France: the EDITH V study","author":"Abramowitz","year":"2009"},{"key":"10.1684\/bdc.2014.2013_bib0180","article-title":"Incidence rates of genital warts in young women and men in France","author":"Aynaud","year":"2011","journal-title":"EUROGIN"},{"key":"10.1684\/bdc.2014.2013_bib0185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","article-title":"Human Papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)","volume":"47","author":"Aubin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1684\/bdc.2014.2013_bib0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jgyn.2013.07.007","article-title":"\u00c0 l\u2019heure du mariage pour tous, peut-on refuser la vaccination HPV pour tous ?","volume":"42","author":"Descamps","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1684\/bdc.2014.2013_bib0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0399-077X(03)00208-7","article-title":"Les vaccins : implications sociales et politiques","volume":"33","author":"Moulin","year":"2003","journal-title":"Med Mal Infect"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:20:31Z","timestamp":1602490831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115300515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":39,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0007455115300515"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2014.2013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}